CMG Pharmaceutical Co. Ltd Tangible Net Worth Ratio
CMG Pharmaceutical Co. Ltd tangible net worth ratio. CMG Pharmaceutical Co. Ltd (058820) has a Tangible Net Worth Ratio of 92.0% as of December 2025. This metric is calculated by deducting intangible assets (₩16.20 Billion) from net assets (₩201.55 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of CMG Pharmaceutical Co. Ltd to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of CMG Pharmaceutical Co. Ltd (2011–2025)
Tangible net worth ratio of CMG Pharmaceutical Co. Ltd from 2011 to 2025. This chart shows how CMG Pharmaceutical Co. Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 92.0%, reflecting net assets of ₩201.55 Billion with intangible assets of ₩16.20 Billion KRW. See how liquid is CMG Pharmaceutical Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
CMG Pharmaceutical Co. Ltd Tangible Net Worth Ratio by Year (2011–2025)
CMG Pharmaceutical Co. Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for CMG Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see CMG Pharmaceutical Co. Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | ₩201.55 Billion | ₩16.20 Billion | ₩305.96 Billion | ▲ +2.1 pp |
| 2024 | 89.8% | ₩189.54 Billion | ₩19.28 Billion | ₩303.44 Billion | ▼ -1.1 pp |
| 2023 | 90.9% | ₩190.23 Billion | ₩17.30 Billion | ₩242.10 Billion | ▼ -1.3 pp |
| 2022 | 92.2% | ₩184.95 Billion | ₩14.39 Billion | ₩213.26 Billion | ▼ -0.9 pp |
| 2021 | 93.1% | ₩184.70 Billion | ₩12.71 Billion | ₩199.17 Billion | ▼ -0.2 pp |
| 2020 | 93.3% | ₩181.13 Billion | ₩12.06 Billion | ₩195.36 Billion | ▼ -0.5 pp |
| 2019 | 93.9% | ₩180.16 Billion | ₩11.08 Billion | ₩192.24 Billion | ▲ +1.6 pp |
| 2018 | 92.2% | ₩103.98 Billion | ₩8.07 Billion | ₩114.38 Billion | ▼ 0.0 pp |
| 2017 | 92.2% | ₩97.94 Billion | ₩7.60 Billion | ₩109.57 Billion | ▲ +5.6 pp |
| 2016 | 86.6% | ₩101.11 Billion | ₩13.55 Billion | ₩110.98 Billion | ▲ +11.7 pp |
| 2015 | 74.9% | ₩46.81 Billion | ₩11.77 Billion | ₩56.53 Billion | ▼ -23.5 pp |
| 2014 | 98.4% | ₩49.00 Billion | ₩793.13 Million | ₩58.07 Billion | ▼ -0.9 pp |
| 2013 | 99.3% | ₩49.00 Billion | ₩363.09 Million | ₩55.91 Billion | ▼ -0.3 pp |
| 2012 | 99.5% | ₩31.59 Billion | ₩154.90 Million | ₩57.11 Billion | ▲ +7.3 pp |
| 2011 | 92.2% | ₩18.03 Billion | ₩1.40 Billion | ₩27.31 Billion | — |